The prescription information comes from 626 pharmacies in 15 states. CVS said it could gain access to 9 million new customers. 

The division develops and manufactures knee and hip replacements, along with other surgical implants. J&J said it will separate DePuy within 18 to 24 months, at which point it will be the largest orthopedics company in the world.

Details are still unclear. However, the administration—along with Pfizer and AstraZeneca, the two companies to sign on—promises the storefront will offer deeply discounted drugs directly to Americans. The deal allows the manufacturers to avoid import tariffs. 

North Carolina–based Advocate Health has installed kiosks at one clinic and one hospital in Chicago, with more on the way. Patients can now pick up common prescriptions without visiting a retail pharmacy.

The new "TrumpRx.com" will sell Pfizer drugs at a heavily discounted price, direct-to-consumers. However, details on the initiative are not entirely clear. 

The U.S. Department of Commerce is investigating domestic medical product manufacturing, as well as imports, to gauge how "state-sponsored overproduction" is impacting supply chain security. 

The settlement was reached with the U.S. Department of Justice as part of Chapter 11 proceedings. Exactech is currently under restructuring that will see its business bought out by multiple investment firms.

In May, a jury found the CVS subsidiary liable for filing 3.3 million fraudulent insurance claims between 2010 and 2018. The $949 million judgment was imposed in July.